Return to Listing

1 result(s) for

PI Name Protocol # Title
Jennifer Saultz STUDY00019290 A Phase 1b Dose-escalation Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PLX2853 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080